학술논문

Real-World Use, Safety, and Patient Experience of 20% Subcutaneous Immunoglobulin for Primary Immunodeficiency Diseases
Document Type
Article
Source
In: Advances in Therapy. (Advances in Therapy, December 2023, 40(12):5168-5187)
Subject
Language
English
ISSN
18658652
0741238X